Opya Raises $15.4 Million Series A Round, Accelerating Leadership in Autism Early Intervention
Opya, the leader in early intervention for autism, today announced it raised $15.4 million in a Series A funding round.
Today, more than 1 in 54 children are diagnosed with autism in the United States, according to the CDC. More than 5 million American adults are on the autistic spectrum. There is a tremendous unmet demand for autism care, with a Stanford study finding that the average demand for treatment is 18 times larger than the available supply. This lack of supply prolongs potential diagnoses, which can greatly hinder early intervention efforts and optimal clinical outcomes.
Opya strives to meet this demand with impactful, high-quality clinical autism care ? through in-home and telehealth therapy. Opya's integrated and multidisciplinary approach weaves together behavioral, speech, and occupational therapy, as well as family training and in-home programs, to empower children newly diagnosed with autism to achieve their goals. By combining the best digital technologies and therapeutic approaches, Opya empowers neurodiverse children and their families to gain the most effective early intervention treatment possible.
The funding comes from new investors including Panoramic Ventures, SB Opportunity Fund, Disability Opportunity Fund, and Raven One Ventures. Prior investors Divergent Investments and Altitude Ventures also participated in this round.
"We are thrilled to be partnering with Alden and the team at Opya," said Austin Poole of Panoramic Ventures. "We believe Opya's outcome-driven approach to serving the neurodiverse population increases much needed access to care while staying laser focused on delivering quality therapy, thus raising the bar in ABA Therapy and improving the lives of the families they serve."
The company, which now has more than 100 employees, plans to use the investment to scale its high-quality clinical care, add top leadership talent, and accelerate its product innovation.
"Our mission is simple: we want to help as many children with autism as possible," said Opya CEO Alden Romney. "We're proud to partner with this distinguished list of investors as we move forward into our next phase of growth. Opya is a mission-driven company with a unique tech-enabled model that is changing the trajectory for children diagnosed with autism."
As part of this fundraise, Austin Poole of Panoramic Ventures will join Opya's Board. Poole will serve alongside current board members, including CEO Alden Romney, Opya founder Jonathan Wright, Jay Zeidman of Altitude Ventures, and Amol Deshpande of Divergent Investments.
About Opya
Opya is the leader in early intervention therapy for children with autism. By combining exceptional clinical treatment with the best of digital technology, Opya is changing how autism care is delivered for children newly diagnosed with autism and transforming the lives of neurodiverse children and their families. Headquartered in the Bay Area, Opya raised more than $15 million in 2021 to scale its platform to help as many children with autism as possible. For more information, connect with us at www.opyacare.com.
News published on and distributed by:
